Characteristic | Malignancy (n = 60) | Non-malignancy (n = 128) | P | ||||||
---|---|---|---|---|---|---|---|---|---|
Total | Survivors (n = 27) | Non-survivors (n = 33) | P | Total | Survivors (n = 88) | Non-survivors (n = 40) | P | ||
Total pSOFA score | 14.0 (12.0–15.0) | 12.0 (10.0–14.0) | 15.0 (14.0–16.0) | <0.01 | 9.0 (8.0–11.0) | 8.0 (7.0–10.0) | 11.0 (9.0–13.0) | <0.01 | <0.01 |
Nervous system | |||||||||
pSOFA score > 0 | 50.0 (83.0) | 22.0 (81.0) | 28.0 (85.0) | 0.728 | 115.0 (90.0) | 77.0 (88.0) | 38.0 (95.0) | 0.193 | 0.204 |
Cardio Vascular system | |||||||||
pSOFA score > 0 | 57.0 (95.0) | 24.0 (89.0) | 33.0 (100.0) | 0.085 | 117.0 (91.0) | 79.0 (90.0) | 38.0 (95.0) | 0.524 | 0.564 |
VIS at peak | 73.0 (20–208) | 35.0 (10.0–80.0) | 180.0 (45.0-338.0) | <0.01 | 15.0 (5.0–82.0) | 10.0 (5.0–39.0) | 79.0 (10.0-195.0) | <0.01 | <0.01 |
Renal | |||||||||
pSOFA score > 0 | 22.0 (37.0) | 7.0 (26.0) | 15.0 (76.0) | 0.118 | 28.0 (22.0) | 16.0 (18.0) | 12.0 (30.0) | 0.134 | 0.032 |
Hematologic | |||||||||
pSOFA score > 0 | 54.0 (90.0) | 23.0 (85.0) | 31.0 (94.0) | 0.489 | 30.0 (23.0) | 17.0 (19.3) | 13.0 (32.5) | 0.103 | <0.001 |
Absolute neutrophil count (× 103/µL) | 0.37 (0.04–1.18) | 0.37 (0.04–1.7) | 0.3 (0.04–0.93) | 0.618 | 5.34 (2.85–9.2) | 4.57 (2.73–8.22) | 7.12 (3.25-11.00) | 0.068 | <0.001 |
Haematoglobin | 70.0 (55.0–82.0) | 69.0 (58.0–87.0) | 70.0 (55.0–80.0) | 0.414 | 90.0 (76.0-106.0) | 92.0 (78.0-108.0) | 84.0 (62.0–98.0) | 0.057 | 0.001 |
Transfusion of Red Blood | 52.0 (87.0) | 22.0 (81.0) | 30.0 (91.0) | 0.448 | 62.0 (48.0) | 39.0 (44.0) | 23.0 (58.0) | 0.167 | 0.028 |
Absolute Platelet counts (× 109/µL) | 17.0 (8.0–73.0) | 21.0 (10.0-110.0) | 16.0 (8.0–43.0) | 0.252 | 232.0 (152.0-330.0) | 246.0 (167.0-335.0) | 206.0 (103.0-309.0) | 0.057 | 0.001 |
Transfusion of Platelet | 44.0 (73.0) | 17.0 (63.0) | 27.0 (82.0) | 0.100 | 18.0 (14.0) | 10.0 (11.0) | 8.0 (20.0) | 0.193 | <0.001 |
Liver | |||||||||
pSOFA score > 0 | 37.0 (62.0) | 16.0 (59.0) | 21.0 (64.0) | 0.729 | 24.0 (19.0) | 14.0 (16.0) | 10.0 (25.0) | 0.222 | <0.001 |
Lactate | 1.5 (0.8–3.7) | 1.2 (0.7-2.0) | 2.7 (1.1–6.3) | 0.006 | 1.0 (0.7-2.0) | 0.9 (0.7–1.6) | 1.6 (0.7–2.9) | 0.02 | 0.008 |
Infection | |||||||||
CRP | 150.0 (83.0-168.0) | 113.0 (78.0-160.0) | 160.0 (100.0-170.0) | 0.096 | 31.0 (10.0-108.0) | 22.5 (9.3–98.8) | 84.0 (10.0-170.0) | 0.02 | <0.001 |
PCT | 10.4 (2.0-27.5) | 3.5 (2.1–15.8) | 16.6 (2.4–32.7) | 0.193 | 1.2 (0.3–6.2) | 0.9 (0.3–5.1) | 2.8 (0.4–11.5) | 0.052 | <0.001 |
Cytokines | |||||||||
IFN-γ | 26.9 (9.1–146.0) | 17.5 (7.3-182.9) | 27.1 (8.0-115.3) | 0.927 | 11.9 (4.9–55) | 11.8 (4.6–41.3) | 26.5 (5.2–62.3) | 0.364 | 0.198 |
IL-6 | 206.3 (21.6-1257.8) | 210.4 (17.5-598.1) | 202.1 (44.4-7421.5) | 0.371 | 99.6 (33.7-266.9) | 96.2 (28.5-203.8) | 109.4 (63-704.5) | 0.032 | 0.205 |
IL-8 | 325.8 (9.0-1119.0) | 84.7 (6.7-507.2) | 540.1 (11.4-4449.5) | 0.181 | 43.0 (18-103.8) | 36.9 (19.0–96.0) | 50.5 (16.1-159.4) | 0.889 | 0.082 |
TNF-α | 4.0 (2.0–10.0) | 3.3 (2.4–10.2) | 3.8 (1.9–9.5) | 0.935 | 3.6 (2.4–8.2) | 3.9 (2.4-8.0) | 3.3 (2.4–11) | 0.654 | 0.926 |
Cellular immunity | |||||||||
CD4 + T | 26.9 (18.5–37.2) | 25.9 (19.2–37.9) | 27.9 (16.4–37.9) | 0.935 | 26.6 (20.0-35.2) | 25.1 (17.2–27.8) | 30.3 (21.6–39.5) | 0.141 | 0.870 |
CD8 + T | 36.9 (26.0-53.6) | 41.6 (32.9–65.4) | 35.9 (21.9–41.3) | 0.113 | 21.9 (17.3–29.1) | 21.4 (17.2–27.8) | 26.3 (16.9–34.3) | 0.202 | <0.001 |
CD19 + T | 9.9 (0.9–30.2) | 6.1 (0.6–20.3) | 18 (3.4–35.2) | 0.173 | 33.6 (22-46.6) | 34.6 (25.3–47.1) | 27.4 (13.9–41.1) | 0.055 | <0.001 |
NK | 4.0 (2.0–10.0) | 3.7 (1.5–10.3) | 4.9 (1.8–9.9) | 0.705 | 5.6 (2.7-9.0) | 5.6 (3.2–9.1) | 5.0 (1.7–9.3) | 0.210 | 0.210 |